PRACTICE
QUESTIONS
Exercise # 25
Q1.
Following are the b2 agonists
a) albuterol
b) terbutaline
c) Theophylline
d) salmeterol
e) a,b,d
Q2.
Prophylaxis of asthma medication include
a) sodium chromoglycate
b) nedocromil sodium
c) ketotifen
d) levabuterol
e) a,b,c
Q3. What
is down regulation in asthma
a) decrease in number of b receptors
b) increase in number of b receptors
c) unable to activate adenyl cyclase
d) can be reversed by cortisones
e)a,c,d
Q4. Which
are the following category of patients should be closely monitered using B
agonist
a. CAD
b. Hyperthyroidism
c. Diabetes
d. Seizures
e. Arrythmias
f.All of above
Q5.
Metered dose inhalers available are
a) terbutaline
b) albuterol
c) Beclomethasone
d) Budesonide
e) all of the above
Q6. Mech of action of b2 agonists
a) stimulate b2 receptors
b) activate adenyl cyclase,activation
of Na,K ATPase
c) increase intra cellular cAMP
d) additional effects of
gluconeogenesis
e) all of the above
Q7. A patient has daily symptoms of asthma, uses
short acting Beta agonist daily, has night time occurrence of symptoms once a
week, and his PEF is > 60 to 80% . His
Asthma severity is classified as
a. Severe persistent
b. Moderate persistent
c. Mild persistent
d. Mild Intermittent
Q8. average PEF volume is
a. 550 to 700 ml per min
b. 1 ltr/min
c. 250 – 350 ml/min
d. 2 ltr/min
Q9. Early asthmatic symptoms is blocked with
a. B agonists
b. Chromolyn Na
c. Nedocromyl
D. Corticosteroids
e. All except D
Q10. Late asthmatic response is treated with
a. B agonists
b. Chromolyn Na
c. Nedocromyl
D. Corticosteroids
e. All except A
New Exercise will
come very soon. Keep in touch with the
website.
No comments:
Post a Comment